Myt-healer: a new potent wound healing peptide

Patent number:

WO20109642

No items found.

The present invention relates to peptides derived from myticin C and to their therapeutic use, more specifically in cell and/or tissue regeneration.

Countries:

Spain

Regions:

Valencian Community

Centers:

CSIC, UNIVERSIDAD MIGUEL HERNANDEZ DE ELCHE

Other entities:

Sectors:

Health

Subsectors:

Pharmaceuticals, Biotechnology

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

SDG03: Good health and well-being

Applications

- Myt-healer is a short peptide, easy to synthesize - Myt-healer can be used both in aqueous solutions or as a part of a releasing device. - Myt-healer activity is retained in the presence of serum components. - Myt-healer shows a strong wound healing: 5 μM Myt-healer seals the induced injury in HaCaT (Culture Human Keratinocyte) monolayer in 24 h.

Comments

Other related patents

Health

ATR inhibitors

Countries

Spain

Health

A method for detecting pseudomonas aeruginosa st175

Countries

Spain

Health

GLUTAMINASE, METHODS AND USES THEREOF

Countries

Portugal

Get back to patents directory